SpringWorks Therapeutics Inc (SWTX)
37.12
+0.30
(+0.83%)
USD |
NASDAQ |
Dec 26, 11:22
SpringWorks Therapeutics Cash from Investing (Quarterly): 28.65M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | -348.00M |
| PTC Therapeutics Inc | -42.68M |
| Blueprint Medicines Corp | 29.95M |
| Edgewise Therapeutics Inc | 25.36M |
| NovaBay Pharmaceuticals Inc | -0.002M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -25.38M |
| Cash from Financing (Quarterly) | 1.291M |
| Free Cash Flow | -221.15M |
| Free Cash Flow Per Share (Quarterly) | -0.3666 |
| Free Cash Flow to Equity (Quarterly) | -27.23M |
| Free Cash Flow Yield | -8.29% |